-
Novo Nordisk's 2023 revenue exceeds 30 billion US dollars, once again verifying the logic of pharmaceutical large single products
On January 31st, Novo Nordisk released its 2023 results, with annual revenue of approximately $33.771 billion, a year-on-year increase of 31%. As a star product of Novo Nordisk, Smegglutide earned ap ... -
Observation of Cultural and Tourism Financial Report | "Ten Thousand Stores" Target Achieved, Huazhu Group's Revenue Increased by 14% in the First Half of the Year, Profit Approaching 2019
21st Century Business Herald reporter Zhang Sai, male intern Yin Xinyu, Shanghai reporting On August 20th, Huazhu Group (NASDAQ: HTHT; Hong Kong Stock Exchange: 1179) released its unaudited financial ...